Loma Linda University
Loma Linda, California, 92350, United States
NCT Number: NCT03176654
This study evaluates the effect of high-velocity low-amplitude thrust (HVLAT) manipulation to the cervical spine on neuropeptide expression as determined by the plasma concentration of oxytocin, neurotensin, orexin A and cortisol; and Examine the effect of HVLAT manipulation on pain perception in symptomatic females with non-specific mechanical cervical spine pain
Looking for future studies?
Notify Me20 year–45 year
Female
Interventional
Not applicable
Loma Linda, California, 92350, United States
A high-velocity low-amplitude thrust (HVLAT) manipulation or commonly known as a spinal manipulation, is an intervention frequently used by physical therapists and other healthcare practitioners as an alternative treatment to help relieve spinal pain The mechanism by which HVLAT manipulation modulates pain remains undefined, although this does not contradict the clinical effects from HVLAT manipulation. Furthermore, there is evidence that suggests analgesia after HVLAT manipulation. There is a variety of observed and proposed phenomena that can explain the mechanisms for the psychological, mechanical, or neurophysiological responses from a HVLAT manipulation associated with alterations in pain processing or sympathetic and motor systems' excitation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
HVLAT will be performed 10 minutes after the first blood draw.
Sham HVLAT will be performed 10 minutes after the first blood draw.
Time frame: Blood will be drawn 10 minutes prior to HVLAT procedure.
Samples were analyzed for Human Oxytocin, using the Multiplex Luminex-100 platform (Luminex, Inc., USA).
Time frame: Blood will be drawn immediately after HVLAT procedure.
Samples were analyzed for Human Oxytocin, using the Multiplex Luminex-100 platform (Luminex, Inc., USA).
Time frame: Within 10 minutes after consent signature completion
Samples were analyzed for Human Neurotensin, using the Multiplex Luminex-100 platform (Luminex, Inc., USA).
Time frame: Blood will be drawn immediately after HVLAT procedure.
Samples were analyzed for Human Neurotensin, using the Multiplex Luminex-100 platform (Luminex, Inc., USA).
Time frame: Within 10 minutes after consent signature completion
Samples were analyzed for Human Orexin A, using the Multiplex Luminex-100 platform (Luminex, Inc., USA).
Time frame: Blood will be drawn immediately after HVLAT procedure.
Samples were analyzed for Human Orexin A, using the Multiplex Luminex-100 platform (Luminex, Inc., USA).
Time frame: Within 10 minutes after consent signature completion
Samples were analyzed for Human Cortisol, using the Multiplex Luminex-100 platform (Luminex, Inc., USA).
Time frame: Blood will be drawn immediately after HVLAT procedure.
Samples were analyzed for Human Cortisol, using the Multiplex Luminex-100 platform (Luminex, Inc., USA).
Loma Linda University
Other
The Effect of High-Velocity Low-Amplitude Thrust Manipulation of the Cervical Spine on Pain Biomarkers in Females With Non-Specific Mechanical Neck Pain
Acronym: HVLAT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03859011
Neck Pain, Neck Pain, Posterior
Jacksonville, Florida, United States
View Trial DetailsNCT05607459
Neck Pain, Neck Pain, Posterior
Alcorcón, Madrid, Spain
View Trial DetailsNCT04256031
Arthralgia, Behavior
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03241134
Neck Pain, Neck Pain, Posterior
Ghent, Oost-Vlaanderen, Belgium
View Trial Details